These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31669511)

  • 1. Pivotal findings for a high-sensitivity cardiac troponin assay: Results of the HIGH-US study.
    Christenson RH; Duh SH; Apple FA; Nowak R; Peacock WF; Limkakeng AT; Bostanian Z; Mohammad A; McCord J; deFilippi CR
    Clin Biochem; 2020 Apr; 78():32-39. PubMed ID: 31669511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical and clinical characterization of a novel high-sensitivity cardiac troponin assay in a United States population.
    Christenson RH; Duh SH; Mullins KE; LeClair MM; Grigorov IL; Peacock WF
    Clin Biochem; 2020 Sep; 83():28-36. PubMed ID: 32485169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study.
    Christenson RH; Peacock WF; Apple FS; Limkakeng AT; Nowak RM; McCord J; deFilippi CR
    Contemp Clin Trials Commun; 2019 Jun; 14():100337. PubMed ID: 30834354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay.
    Christenson RH; Mullins K; Duh SH
    Clin Biochem; 2018 Jun; 56():4-10. PubMed ID: 29750939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-specific 99th percentiles derived from the AACC Universal Sample Bank for the Roche Gen 5 cTnT assay: Comorbidities and statistical methods influence derivation of reference limits.
    Gunsolus IL; Jaffe AS; Sexter A; Schulz K; Ler R; Lindgren B; Saenger AK; Love SA; Apple FS
    Clin Biochem; 2017 Dec; 50(18):1073-1077. PubMed ID: 28916437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the analytical and clinical performance of a new high-sensitivity cardiac troponin I assay: hs-cTnI (CLIA) assay.
    Li L; Shu X; Zhang L; Xu A; Yang J; Jing Y; Wang H; Zhang Z
    Clin Chem Lab Med; 2024 Jan; 62(2):353-360. PubMed ID: 37746851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the new Beckman Coulter Access hsTnI: 99th percentile upper reference limits according to age and sex in the Korean population.
    Kim S; Yoo SJ; Kim J
    Clin Biochem; 2020 May; 79():48-53. PubMed ID: 32059836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay.
    Apple FS; Schulz K; Schmidt CW; van Domburg TSY; Fonville JM; de Theije FK
    Clin Chem Lab Med; 2021 Aug; 59(9):1574-1578. PubMed ID: 34022125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single test rule-out of acute myocardial infarction using the limit of detection of a new high-sensitivity troponin I assay.
    Body R; Morris N; Collinson P
    Clin Biochem; 2020 Apr; 78():4-9. PubMed ID: 32135083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-Specific 99th Percentile Upper Reference Limits for High Sensitivity Cardiac Troponin Assays Derived Using a Universal Sample Bank.
    Apple FS; Wu AHB; Sandoval Y; Sexter A; Love SA; Myers G; Schulz K; Duh SH; Christenson RH
    Clin Chem; 2020 Mar; 66(3):434-444. PubMed ID: 32109298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction.
    Pickering JW; Greenslade JH; Cullen L; Flaws D; Parsonage W; George P; Worster A; Kavsak PA; Than MP
    Heart; 2016 Aug; 102(16):1270-8. PubMed ID: 26955848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction.
    Keller T; Zeller T; Ojeda F; Tzikas S; Lillpopp L; Sinning C; Wild P; Genth-Zotz S; Warnholtz A; Giannitsis E; Möckel M; Bickel C; Peetz D; Lackner K; Baldus S; Münzel T; Blankenberg S
    JAMA; 2011 Dec; 306(24):2684-93. PubMed ID: 22203537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-Care: Roadmap for Analytical Characterization and Validation of a High-Sensitivity Cardiac Troponin I Assay in Plasma and Whole Blood Matrices.
    Christenson RH; Frenk LDS; de Graaf HJ; van Domburg TSY; Wijnands FPG; Foolen HWJ; Kemper DWM; Bruinen AL; Meijering BDM; Fonville JM; de Theije FK
    J Appl Lab Med; 2022 Jun; 7(4):971-988. PubMed ID: 35660917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical performance comparing siemens whole blood point of care Atellica VTLi to the central laboratory plasma Atellica IM high-sensitivity cardiac troponin I assays.
    Xiong-Hang K; Schulz K; Sandoval Y; Smith SW; Saenger AK; Apple FS
    Clin Biochem; 2023 Apr; 114():79-85. PubMed ID: 36780933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin.
    Boeddinghaus J; Reichlin T; Nestelberger T; Twerenbold R; Meili Y; Wildi K; Hillinger P; Giménez MR; Cupa J; Schumacher L; Schubera M; Badertscher P; Corbière S; Grimm K; Puelacher C; Sabti Z; Widmer DF; Schaerli N; Kozhuharov N; Shrestha S; Bürge T; Mächler P; Büchi M; Rentsch K; Miró Ò; López B; Martin-Sanchez FJ; Rodriguez-Adrada E; Morawiec B; Kawecki D; Ganovská E; Parenica J; Lohrmann J; Buser A; Keller DI; Osswald S; Mueller C
    Clin Res Cardiol; 2017 Jun; 106(6):457-467. PubMed ID: 28150185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of presentation and 4-hour high sensitivity troponin I to rule-out acute myocardial infarction in the emergency department.
    Pickering JW; Young JM; George P; Aldous S; Cullen L; Greenslade JH; Richards AM; Troughton R; Ardagh M; Frampton CM; Than MP
    Clin Biochem; 2015 Dec; 48(18):1219-24. PubMed ID: 26232285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Outlier Elimination on the 99th Percentile Upper Reference Limits of High-Sensitivity Cardiac Troponin I Assays Based on a Strictly Selected Healthy Reference Population.
    Ahn S; Kim HK; Lee W; Chun S; Min WK
    Ann Lab Med; 2022 May; 42(3):331-341. PubMed ID: 34907103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison of clinical decision limits for cardiac troponin T and I.
    Kimenai DM; Henry RM; van der Kallen CJ; Dagnelie PC; Schram MT; Stehouwer CD; van Suijlen JD; Niens M; Bekers O; Sep SJ; Schaper NC; van Dieijen-Visser MP; Meex SJ
    Heart; 2016 Apr; 102(8):610-6. PubMed ID: 26794233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Age- and Sex-Specific 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin I in Healthy Chinese Adults.
    He B; Wang K; Xu P; Zhou Q; Xu J
    Cardiology; 2022; 147(3):261-270. PubMed ID: 35220311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay.
    Krintus M; Kozinski M; Boudry P; Capell NE; Köller U; Lackner K; Lefèvre G; Lennartz L; Lotz J; Herranz AM; Nybo M; Plebani M; Sandberg MB; Schratzberger W; Shih J; Skadberg Ø; Chargui AT; Zaninotto M; Sypniewska G
    Clin Chem Lab Med; 2014 Nov; 52(11):1657-65. PubMed ID: 24897400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.